PMCPA Case
| Case numbers | AUTH/2070/11/07; AUTH/2072/12/07; AUTH/2073/12/07 |
| Parties | Anonymous complainants v Otsuka Pharmaceuticals (UK) Ltd and Bristol-Myers Squibb Pharmaceuticals Ltd |
| Product | Abilify (aripiprazole) |
| Issue | Alleged inappropriate hospitality/meeting arrangements for South Asian Psychiatric Forum meeting |
| Meeting | “Recent Advances in Management of Schizophrenia” (Birmingham) |
| Scientific content | 6 hours 30 minutes (1.5 hours Friday evening; 5 hours Saturday) |
| Attendance | 69 health professionals attended; plus 5 speakers and a chairperson |
| Accommodation | 39 of 69 delegates stayed overnight on Friday |
| Spouse/partner attendance | Only spouses who were health professionals and delegates in their own right (five couples) |
| Hospitality costs (stated) | Friday meal/beverages £36.81 per head; overall cost per head £134.20; total cost £9,259.58 |
| Entertainment | None provided (as stated by companies and accepted by Panel) |
| Applicable Code year | 2006 |
| Clauses considered | 2, 9.1, 19.1 |
| Decision | No breach |
| Complaint received | 28 November 2007 (AUTH/2070/11/07); 3 December 2007 (AUTH/2072/12/07; AUTH/2073/12/07) |
| Case completed | 7 January 2008 |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.